Nantahala Capital Management - APOLLO ENDOSURGERY INC ownership

APOLLO ENDOSURGERY INC's ticker is APEN and the CUSIP is 03767D108. A total of 29 filers reported holding APOLLO ENDOSURGERY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of APOLLO ENDOSURGERY INC
ValueSharesWeighting
Q1 2023$65,224,208
+8.0%
6,575,021
+8.6%
5.00%
+27.7%
Q4 2022$60,384,571
+83.5%
6,056,627
+1.4%
3.91%
+83.7%
Q3 2022$32,916,000
+69.4%
5,973,906
+12.2%
2.13%
+118.7%
Q2 2022$19,429,000
-13.8%
5,323,010
+42.9%
0.97%
-2.3%
Q1 2022$22,536,000
-28.9%
3,724,899
-1.0%
1.00%
-10.7%
Q4 2021$31,712,000
+39.2%
3,761,783
+49.6%
1.12%
+55.4%
Q3 2021$22,780,000
+21.4%
2,514,328
+8.5%
0.72%
+34.7%
Q2 2021$18,772,000
+49.4%
2,317,491
+1.6%
0.53%
+45.2%
Q1 2021$12,563,000
+61.4%
2,279,970
-0.4%
0.37%
+52.3%
Q4 2020$7,783,000
+140.6%
2,289,263
+19.6%
0.24%
+143.4%
Q3 2020$3,235,000
+7.0%
1,913,972
+3.5%
0.10%
+8.8%
Q2 2020$3,023,000
-14.8%
1,848,6720.0%0.09%
-31.6%
Q1 2020$3,549,000
-32.8%
1,848,672
+2.1%
0.13%
-18.4%
Q4 2019$5,278,000
-11.4%
1,810,5620.0%0.16%
-26.2%
Q3 2019$5,957,000
+1.2%
1,810,5620.0%0.22%
+22.1%
Q2 2019$5,884,000
-17.7%
1,810,562
-5.2%
0.18%
-18.8%
Q1 2019$7,146,000
+17.6%
1,910,562
+8.5%
0.22%
+19.3%
Q4 2018$6,074,000
-28.9%
1,760,562
+47.7%
0.19%
-18.7%
Q3 2018$8,547,000
+88.4%
1,191,985
+83.4%
0.23%
+25.0%
Q2 2018$4,537,000649,9410.18%
Other shareholders
APOLLO ENDOSURGERY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Parian Global Management LP 732,966$2,675,00012.25%
Stonepine Capital Management, LLC 2,161,999$7,891,0003.67%
Gagnon Advisors, LLC 1,329,354$4,852,0002.94%
CPMG Inc 3,905,225$14,254,0002.86%
Soleus Capital Management, L.P. 3,268,948$11,932,0001.86%
GAGNON SECURITIES LLC 1,796,500$6,557,0001.37%
SILVERARC CAPITAL MANAGEMENT, LLC 1,074,879$3,923,0001.21%
Parkman Healthcare Partners LLC 650,000$2,373,0000.87%
Archon Capital Management LLC 954,696$3,485,0000.80%
Nantahala Capital Management 3,723,010$13,589,0000.68%
View complete list of APOLLO ENDOSURGERY INC shareholders